Ventac Partners
Lars Hedbys is the Chairman of the Board at Chosa Oncology and Strominnate Therapeutics AB. Additionally, Lars serves as a Board Member at Xintela AB, Asgard Therapeutics, and Cell Invent AB. Lars is also a Member of the Board at RhoVac and a Partner at Ventac Partners, a life science consulting firm. With a Ph.D. in Applied Biochemistry from Lund University and a M.Sc. in Chemical Engineering from Chalmers University of Technology, Lars Hedbys has a strong background in the life science industry and brings valuable expertise to the companies Lars is involved with.
This person is not in any offices
Ventac Partners
1 followers
With offices across Europe, United States and Asia and with our multi-disciplinary Partner and Advisor teams, Ventac Partners strives to provide its clients superior global services delivered locally. Covering Biotech, Pharma and Medtech, we offer hands-on experience and skills required to drive innovative technology-based projects from the laboratory to the market. Over the last 15 years, we have experienced a steadily growing business with industry and academic institutions, we have founded, incorporated and exited several companies together with our partners and investors and consulted on hundreds of different early stage or advanced projects. Ventac Partners is continuously expanding its international presence and remains committed to generate value to its clients and portfolio company partners and investors.